Page 2 - Feops Heartguide News Today

/PRNewswire/ -- Abbott (NYSE: ABT) today announced data from five late-breaking presentations showing the benefits of its minimally invasive devices in...

/PRNewswire/ -- Abbott (NYSE: ABT) today announced data from five late-breaking presentations showing the benefits of its minimally invasive devices in...

Five late-breaking presentations at TCT 2022 highlight the impact of Abbotts structural heart devices to repair or replace heart valves and close openings in the heartNew data reinforce the safety...

Press release content from Business Wire. The AP news staff was not involved in its creation.

A technology company using modeling tools to help their customers improve the design, safety and efficacy of medical devices tailored to individual...

FEops, a cloud-based digital health player in the structural heart space, is glad to announce the nomination of Euan Thomson as a board member to its Board of Directors. "We are delighted to welcome

FEops today announced that it received De Novo authorization from the U.S. Food and Drug Administration (FDA) for FEops HEARTguide pre-operative planning of left atrial appendage occlusion with the

FEops, a leader in predictive planning for structural heart interventions, is proud to announce that its simulation technology supported TRiCares from initial design concept to a successful first-in-human

FEops strengthens its position as the cloud-based digital health player in the structural heart space by introducing Artificial Intelligence into its CE marked FEops HEARTguide platform. This press

Press release content from Business Wire. The AP news staff was not involved in its creation. FEops Announces 2.000 Patients Modelled With FEops HEARTguide™ February 1, 2021 GMT GENT, Belgium--(BUSINESS WIRE)--Feb 1, 2021-- FEops, a digital health leader in personalized predictive planning for structural heart interventions, is proud to announce having modeled 2000 patients with FEops HEARTguide™ for the pre-operative planning of structural heart interventions. FEops HEARTguide™ is curren...